Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00831051 · ClinicalTrials.gov registry record · Phase 2
Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients
A Phase 2 study, sponsored by QRxPharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 197
- Enrollment target
NCT00831051 is a Phase 2 study that has completed, run by QRxPharma. The registered enrollment target is 197 participants.
The verdict
NCT00831051, a Phase 2 study, has completed, sponsored by QRxPharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 197 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, multicenter, fixed dose factorial study of Q8003 12 mg/8 mg and Q8003 6 mg/4 mg versus its individual morphine sulfate and oxycodone hydrochloride components for the management of acute moderate to severe postoperative pain following bunionectomy surgery.
Interventions
- DRUG Morphine sulfate
- DRUG Oxycodone HCl
- DRUG Q8003
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00831051
The ClinicalTrials.gov registry entry for NCT00831051 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is QRxPharma, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Morphine sulfate is the first listed.
NCT00831051 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00831051 about?
NCT00831051 is a clinical study titled "Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients". This is a randomized, double-blind, multicenter, fixed dose factorial study of Q8003 12 mg/8 mg and Q8003 6 mg/4 mg versus its individual morphine sulfate and oxycodone hydrochloride components for the management of acute moderate to severe postoperative pain following bunionectomy surgery.
What is the current status of trial NCT00831051?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 197 participants. The study started on 2008-12. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00831051?
The interventions under investigation include: Morphine sulfate (DRUG), Oxycodone HCl (DRUG), Q8003 (DRUG).
Who is sponsoring clinical trial NCT00831051?
This trial is sponsored by QRxPharma, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.